The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study
- Ariel Hammerman
- , Sari Greenberg-Dotan
- , Erez Battat
- , Ilan Feldhamer
- , Haim Bitterman
- , Baruch Brenner
Research output: Contribution to journal › Article › peer-review